{
  "id": "5c2b83b266b5a929",
  "title": "STAT+: Dyne Therapeutics plans to file for approval for next-generation Duchenne drug",
  "description": "Dyne Therapeutics plans to submit its next-gen Duchenne muscular dystrophy drug to the FDA after a successful trial.",
  "content": "Dyne Therapeutics plans to submit its next-gen Duchenne muscular dystrophy drug to the FDA after a successful trial.",
  "source": "STAT",
  "source_url": "https://www.statnews.com/2025/12/08/dyne-therapeutics-duchenne-fda-exon-skipper-sarepta/?utm_campaign=rss",
  "published_at": "2025-12-08T11:36:08+00:00",
  "fetched_at": "2025-12-09T00:22:19.510482+00:00",
  "category": "health_biotech",
  "subcategory": null,
  "keywords": [
    "fda",
    "drug"
  ],
  "location": null,
  "raw_data": {
    "title": "STAT+: Dyne Therapeutics plans to file for approval for next-generation Duchenne drug",
    "description": "Dyne Therapeutics plans to submit its next-gen Duchenne muscular dystrophy drug to the FDA after a successful trial.",
    "url": "https://www.statnews.com/2025/12/08/dyne-therapeutics-duchenne-fda-exon-skipper-sarepta/?utm_campaign=rss",
    "published": "2025-12-08T11:36:08+00:00",
    "source": "STAT"
  }
}